Barry Jones

74 year

Health Technology

Consumer Services

Profile

Barry Jones has served as Senior Vice President of Research since January 2003 and as Vice President of Research since March 2002, the date of the merger with Point Massachusetts and as Vice President of Research of Point Massachusetts since January 2000, and Director of Immunology of Point Massachusetts since 1997.
Prior to joining Point Massachusetts, he was Director of Immunology at Procept, Inc., from 1993 through July 1997.
He has also held academic research positions at Yale University's School of Medicine and at Pennsylvania State University.

Former positions of Barry Jones

Companies	Position	End
Point Therapeutics, Inc. Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA.	Chief Tech/Sci/R&D Officer	-
Procept, Inc. Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA	Corporate Officer/Principal	-
ALAUNOS THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	22/10/2009

See the detail of Barry Jones's experience

Training of Barry Jones

Northeastern University	Undergraduate Degree
University of Bristol	Doctorate Degree
The University of Liverpool	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies